micro dose glp 1 Is It Smart For You To "Microdose" GLP-1s? THE GLP-1 MICRODOSING PROGRAM

One unit always equals 0.01 ml

In SURMOUNT-1 (Phase 3), tirzepatide at 15 mg produced 22.5% body weight loss at 72 weeks

BMI, cardiovascular risk factors, and patient preference into consideration

This supplement can cause serious side effects

Furthermore, alongside the increasing prevalence of related cardiometabolic diseases such as diabetes, obesity and chronic kidney disease (CKD), the number of people with HF has increased to around 64 million globally, amongst whom most are also living with type 2 diabetes or obesity ( Within the past 2 decades, glucagon-like peptide-1 (GLP-1) receptor agonists (RAs) have emerged as effective agents to improve glycaemic control in type 2 diabetes and to reduce body weight in people with overweight or obesity (Sattar et al., 2021

It's easy to use, widely available, and for many people, it's the first treatment worth trying